Perforin detection as specific tumor marker for UrothelialCancer inPatients
DOI:
https://doi.org/10.36320/ajb/v10.i2.8122Keywords:
Perforin, tumor marker , Urothelial CancerAbstract
Perforin″PRF1″ is a fenestrae-framing peptide whichhas the capacity of ″toxic lymphocytes″, which slaughter changed cells as well as cells harboring intracellular pathogens(Voskoboinik and Trapani 2006).These lymphocytes traverse both the intrinsic and versatile safe compartments, and include ″toxic T lymphocytes″, regular executioner killer cells, Natural killercells.Thesecytes can release ″PRF1″continuously sending warning signals.″PRF1″ is placed in the cellular parts that are released in a cellular way to empty their contents, performing their role as target cells (Voskoboiniket.al 2010).
Downloads
References
Baumgart E, Cohen MS, Silva Neto B, Jacobs MA, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M, Libertino JA, Summerhayes IC. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 2007; 13: 1685–89.
Beseničar MP, Metkar S, Wang B, Froelich CJ, Anderluh G. Granzyme B translocates across the lipid membrane only in the presence of lytic agents. BiochemBiophys Res Commun 2008; 371: 391–4.
Black PC, Dinney CPN. Bladder cancer angiogenesis and metastatis-translation from murine model to clinical trial. Cancer Metastatis Rev 2007; 26: 623–634.
Bleackley RC. A molecular view of cytotoxic T lymphocyte induced killing. Biochem Cell Biol 2005; 83: 747–51.
Bryan RT, Atherfold PA, Yeo Y, Jones LJ, Harrison RF, Wallace DM, Jankowski JA. Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies. J Pathol 2008; 215: 184–94.
Buzza MS, Zamurs L, Sun J, Bird CH, Smith AI, Trapani JA, Froelich CJ, Nice EC, Bird PI. Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin and laminin. J BiolChem 2005; 280: 23549–558.
Chia J ,Yeo KP ,Whisstock JC ,Dunstone MA ,Trapani JA ,Voskoboinik I (2009) Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity ,delayed FHL ,and predisposition to cancer .ProcNatlAcadSci USA ,106:9809-14.
Chowdhury D, Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol 2008; 26: 389–420.
Cullen SP, Martin S. Mechanisms of granule-dependent killing. Cell Death Differ 2008; 15: 251–62.
Donatella D ,Paola P ,Chiara R ,Cosimo D ,Stefania M ,Angela S ,Antonella S and Francessca V (2010 ) Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion .Int.J.Cancer:127,1283-1294.
EbleJN, SauterG, EpsteinJI, SesterhennIA, eds. World Health Organization (WHO) classification of tumors of the urinary system and male genital organs. Lyon: IARC Press, 2004. 90–92.
Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161–74.
Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, Bittard H. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res 2006; 12: 2780–7.
Lin W, Rahman NA, Lin J, Zhang H, Gou K, Yu W, Zhu D, Li N, Huhtaniemi I and Li X(2011) Molecular mechanisms of bladder outlet obstruction in transgenic male mice overexpressing aromatase .Am J Pathol ,178:1233–1244.
Lipponen PK, Eskelinen MJ. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J Cancer Res ClinOncol 1995; 121: 303–8.
O'Brien P, O'Connor BF. Seprase: an overview of an important matrix serine protease. BiochimBiophysActa 2008; 1784: 1130–45.
Rosado CJ, Buckle AM, Law RH, Butcher RE, Kan WT, Bird CH, Ung K, Browne KA, Baran K, Bashtannyk-Puhalovich TA, Faux NG, Wong W, Porter CJ, Pike RN, Ellisdon AM, Pearce MC, Bottomley SP, Emsley J, Smith AI, Rossjohn J, Hartland EL, Voskoboinik I, Trapani JA, Bird PI, Dunstone MA, Whisstock JC (2007). "A common fold mediates vertebrate defense and bacterial attack". Science. 317 (5844): 1548–51.
Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002; 20: 323–70.
Thiery J, Keefe D, Boulant S, Boucrot E, Walch M, Martinvalet D, Goping IS, Bleackley RC, Kirchhausen T, Lieberman J (2011). "Perforin pores in the endosomal membrane trigger the release of endocytosedgranzyme B into the cytosol of target cells". Nat. Immunol. 12 (8): 770
Thiery JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131–42.
Trapani JA (1996). "Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B". Australian and New Zealand journal of medicine. 25 (6): 793–9.
Truls, G., Kennet, W. and Jörgen, C. (2005) Analysis of Her2/neu Expression in Primary Bladder Carcinoma and Corresponding Metastases. Journal of Pathology, 95, 982-986
Tschopp J, Masson D, Stanley KK (1986). "Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis". Nature. 322 (6082): 831–4
Voskoboinik I ,Dunstone MA ,Baran K ,Whisstock JC ,Trapani JA (2010) Perforin :structure ,function , and role in human immunopathology.Immunol Rev,235 :35-54.
Voskoboinik I ,Smyth MJ and Trapani JA (2006) Perforin- mediated target-cell death and immune homeostasis .Nat Rev Immunol ,6:940-52.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Hanan D. Abbas, Rawaa Abdul-Ameer Abdul-Jabbar
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
